BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Turn Bio Acquires ARMMs Technology to Advance Precision Epigenetic Therapies Across More Tissues and Indications

ARMMs brings precision medicine through targeted, non-viral vesicular delivery Synergy of ARMMs and eTurna™ LNP platforms means company can delive...

March 27, 2025 | News

SineuGene Therapeutics Receives FDA IND Clearance for First-in-Class ALS Gene Therapy SNUG01

SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, announce...

March 25, 2025 | News

Porton Advanced and Eureka Therapeutics Partner to Advance Next-Gen T-Cell Therapies

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

March 20, 2025 | News

Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation

What are the most significant recent breakthroughs in cell and gene therapy and how is Thermo Fisher Scientific involved in these advancements? In 2024, t...

March 14, 2025 | Interaction

CARsgen Doses First SLE Patient with KJ-C2219, a Dual-Target Allogeneic CAR-T Therapy

CARsgen Therapeutics Holdings Limited a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tu...

February 28, 2025 | News

CARsgen Therapeutics and Zhuhai SB Xinchuang Partner to Advance Allogeneic CAR-T Therapies in China

CARsgen Therapeutics Holdings Limited , a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors...

February 26, 2025 | News

Andelyn Biosciences Expands AAV Curator™ Platform with Broad Institute’s CNS Capsids to Advance Gene Therapy for Neurological Diseases

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has expand...

February 21, 2025 | News

Restore Vision Doses First Patient in World’s First Optogenetic Gene Therapy Trial for Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial. R...

February 14, 2025 | News

Lion TCR Secures FDA Clearance for Phase 2 Trial of Pioneering mRNA TCR-T Therapy for Liver Cancer

Lion TCR announced that its mRNA-encoded T-cell receptor (TCR)-T cell therapy product Liocyx-M004 has received clearance from the U.S. Food and Drug A...

February 12, 2025 | News

PHC Corporation Partners with CCRM to Advance T-Cell Expansion for Cell and Gene Therapies

PHC Corporation has signed a Master Collaboration Agreement with CCRM, a global leader in regenerative medicine and biomanufacturing, to jointly develop pr...

February 12, 2025 | News

Bristol Myers Squibb’s Breyanzi Recommended for EU Approval After 97% Response Rate in Follicular Lymphoma

Recommendation based on the Phase 2 TRANSCEND FL study in which 97.1% of patients responded to Breyanzi, with 94.2% of patients achieving comple...

February 03, 2025 | News

VectorBuilder’s Partner Ucello Secures FDA IND Approval for UC101, the World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Therapy

VectorBuilder's partner, Ucello, announced that its CD19-targeting umbilical cord blood-derived allogeneic CAR-T cell therapy, UC101, received Investi...

January 30, 2025 | News

CPC Introduces MicroCNX® Nano Series Connectors to Streamline Cell and Gene Therapy Processing

CPC (Colder Products Company), part of Dover (NYSE: DOV) and a leading manufacturer of connection technologies used in biopharmaceutic...

January 30, 2025 | News

GC Cell Hosts Landmark Symposium in Indonesia to Spotlight Immuncell-LC Cancer Immunotherapy

GC Cell, a leading cell and gene therapy company, announced the successful completion of its first thought leadership symposium in Jakarta, Indonesia....

January 24, 2025 | News

Stay Connected